Abortion Health Reproductive Rights

Attorneys General Urge the FDA to Allow Use of Mifepristone by Mail During COVID-19 Pandemic

In response to abortion-related concerns taking place during the COVID-19 outbreak, a group of 21 attorneys general are urging the federal government to allow pregnant individuals to use mifepristone if they would like to terminate their pregnancy without unnecessary travel. According to Huffington Post senior reporter Melissa Jeltsen, the current system in place requires that […]


FDA Approves First Drug for Postpartum Depression, but Could Cost Up to $34,000

The Food and Drug Administration approved brexanolone, an intravenous medication specifically designed to treat postpartum depression that is expected to be sold under the brand name Zulresso in June, for a hefty price tag of about $34,000. The drug works quickly, with effects taking place within 48 hours. However, the medication itself is delivered by […]

Reproductive Rights

Michigan House Renews Telemedicine Abortion Ban

Early Thursday morning, the Michigan statehouse passed a bill renewing the 2012 “telemedicine ban,” which is set to expire at the end of December. Governor Snyder is expected to sign the bill into law before the New Year when newly-elected Democratic Governor Gretchen Whitmer takes office. The “telemedicine ban” prevents doctors from prescribing an abortion-inducing […]


Mifepristone: More Than An Abortion Pill – A Lifesaver for Women

Although drug mifepristone is most commonly used for early abortion, Beth Jordan, MD., explains why it should also be widely available to treat life-saving medical and mental health conditions that disproportionately impact women.


Supreme Court to Decide New Abortion Pill Case

An Oklahoma law that could outlaw all drug-induced abortions – and could have a sweeping impact on other abortion laws across the nation – is headed to the U.S. Supreme Court.